By expenditures
| Name | Title | Type |
|---|---|---|
| Susie Novak Boelter | EXECUTIVE DIRECTOR | Auditee |
| Ashley Engel | Shareholder | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 340321 | 2024 | 2025-01-29 | Brady Martz & Associates PC | $3.59M |
| 290308 | 2023 | 2024-02-13 | Brady Martz & Associates PC | $2.70M |
| 51248 | 2022 | 2023-03-03 | Brady Martz & Associates PC | $2.51M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 340321 | 2024 | 2025-01-29 | 1097092 | 2024-003 | Significant Deficiency | - | E |
| 340321 | 2024 | 2025-01-29 | 1097091 | 2024-002 | Significant Deficiency | - | AB |
| 340321 | 2024 | 2025-01-29 | 1097090 | 2024-003 | Significant Deficiency | - | E |
| 340321 | 2024 | 2025-01-29 | 1097089 | 2024-003 | Significant Deficiency | - | E |
| 340321 | 2024 | 2025-01-29 | 1097088 | 2024-003 | Significant Deficiency | - | E |
| 340321 | 2024 | 2025-01-29 | 1097087 | 2024-002 | Significant Deficiency | - | AB |
| 340321 | 2024 | 2025-01-29 | 1097086 | 2024-002 | Significant Deficiency | - | AB |
| 340321 | 2024 | 2025-01-29 | 1097085 | 2024-002 | Significant Deficiency | - | AB |
| 340321 | 2024 | 2025-01-29 | 520650 | 2024-003 | Significant Deficiency | - | E |
| 340321 | 2024 | 2025-01-29 | 520649 | 2024-002 | Significant Deficiency | - | AB |
| 340321 | 2024 | 2025-01-29 | 520648 | 2024-003 | Significant Deficiency | - | E |
| 340321 | 2024 | 2025-01-29 | 520647 | 2024-003 | Significant Deficiency | - | E |
| 340321 | 2024 | 2025-01-29 | 520646 | 2024-003 | Significant Deficiency | - | E |
| 340321 | 2024 | 2025-01-29 | 520645 | 2024-002 | Significant Deficiency | - | AB |
| 340321 | 2024 | 2025-01-29 | 520644 | 2024-002 | Significant Deficiency | - | AB |
| 340321 | 2024 | 2025-01-29 | 520643 | 2024-002 | Significant Deficiency | - | AB |
| 290308 | 2023 | 2024-02-13 | 943632 | 2023-002 | Significant Deficiency | - | AB |
| 290308 | 2023 | 2024-02-13 | 367190 | 2023-002 | Significant Deficiency | - | AB |
| 51248 | 2022 | 2023-03-03 | 622487 | 2022-003 | Significant Deficiency | - | I |
| 51248 | 2022 | 2023-03-03 | 622486 | 2022-002 | Significant Deficiency | - | ABH |
| 51248 | 2022 | 2023-03-03 | 46045 | 2022-003 | Significant Deficiency | - | I |
| 51248 | 2022 | 2023-03-03 | 46044 | 2022-002 | Significant Deficiency | - | ABH |